| Dr Patrick Martin Ray, DC | |
|
121 Executive Dr, Madison, MS 39110-9198 | |
| (601) 856-8850 | |
| (601) 856-8957 |
| Full Name | Dr Patrick Martin Ray |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 17 Years |
| Location | 121 Executive Dr, Madison, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013114982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1207 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jeffery P Jones Dc | 1759670425 | 4 |
News Archive
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
News outlets examine how the overhaul is being used in campaign ads in North Carolina, where a primary election is being held today, as well as in Iowa. Meanwhile, in Tennessee, the political spin has raised some eyebrows.
Michelle's Miracle, Inc the leading provider of tart cherry nutraceutical products announced that it has closed its first tranche of Series A funding after raising approximately $750,000 in equity.
Researchers at North Carolina State University have found that the overproduction of a key protein in stem cells causes those stem cells to form cancerous tumors. Their work may lead to new treatments for a variety of cancers.
› Verified 1 days ago
| Provider Name | Jeffery P Jones Dc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184079832 PECOS PAC ID: 1759670425 Enrollment ID: O20160519000533 |
News Archive
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
News outlets examine how the overhaul is being used in campaign ads in North Carolina, where a primary election is being held today, as well as in Iowa. Meanwhile, in Tennessee, the political spin has raised some eyebrows.
Michelle's Miracle, Inc the leading provider of tart cherry nutraceutical products announced that it has closed its first tranche of Series A funding after raising approximately $750,000 in equity.
Researchers at North Carolina State University have found that the overproduction of a key protein in stem cells causes those stem cells to form cancerous tumors. Their work may lead to new treatments for a variety of cancers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick Martin Ray, DC 121 Executive Dr, Madison, MS 39110-9198 Ph: (601) 856-8850 | Dr Patrick Martin Ray, DC 121 Executive Dr, Madison, MS 39110-9198 Ph: (601) 856-8850 |
News Archive
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
News outlets examine how the overhaul is being used in campaign ads in North Carolina, where a primary election is being held today, as well as in Iowa. Meanwhile, in Tennessee, the political spin has raised some eyebrows.
Michelle's Miracle, Inc the leading provider of tart cherry nutraceutical products announced that it has closed its first tranche of Series A funding after raising approximately $750,000 in equity.
Researchers at North Carolina State University have found that the overproduction of a key protein in stem cells causes those stem cells to form cancerous tumors. Their work may lead to new treatments for a variety of cancers.
› Verified 1 days ago
Jones Chiropractic Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 121 Executive Dr, Madison, MS 39110 Phone: 601-856-8850 Fax: 601-856-8957 | |
Dr. Jessica Ray, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 121 Executive Dr, Madison, MS 39110 Phone: 940-231-2980 | |
Livfree Chiropractic Holistic Wellness Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 986 Madison Ave Ste 1a, Madison, MS 39110 Phone: 214-329-8322 | |
Jeffery P Jones Dc Chiropractor Medicare: Medicare Enrolled Practice Location: 121 Executive Dr, Madison, MS 39110 Phone: 601-856-8850 Fax: 601-856-8957 | |
Marshall L Jones, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 737 Highway 51, Building A-1, Madison, MS 39110 Phone: 601-856-8850 Fax: 601-856-8957 | |
Ashlyn Lavender, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 121 Executive Dr, Madison, MS 39110 Phone: 601-856-8850 |